FREEDOM-1 and FREEDOM-1 High Baseline (HBL) study showed positive results when the continuous subcutaneous infusion of exenatide is added to standard oral diabetes medications…. ITCA 650 is a continuous subcutaneous infusion of exenatide through a pump for the treatment of type 2 diabetes. FREEDOM-1 is a double blinded, randomized, placebo-controlled, multicenter, phase …
Read More »Gout Linked to Increased Type 2 Diabetes Risk
Gout appears to increase the risk of type 2 diabetes, especially in women…. Researchers followed more than 35,000 gout sufferers in the United Kingdom and found that women with gout were 71 percent more likely to develop diabetes compared with people without gout. For men, the increased risk was 22 …
Read More »Study of Identical Twins Reveals Type 2 Diabetes Clues
By studying identical twins, researchers have identified mechanisms that could be behind the development of type 2 diabetes…. The study involved 14 pairs of identical twins in Sweden and Denmark. One of each twin had type 2 diabetes while the other was healthy. Emma Nilsson, the researcher who carried out …
Read More »EASD: Type 2 Diabetes plus Ischemic Heart Disease Can Predict Mortality
Long-term mortality of patients with ischemic heart disease is independently predicted by diabetes…. Anna Norhammar, MD, PhD, of the cardiology unit in the department of medicine at Karolinska Institutet in Sweden, said during her presentation, “Diabetes is common among patients with heart failure that report ischemic heart disease and it’s …
Read More »Exercise May Not Reduce Type 2 Diabetes Risk as Much in People with Increased Genetic Risk
“An interaction of genetic risk with physical activity on incident type 2 diabetes that appears to be driven principally through genetic risk to insulin resistance.”… Yann C. Klimentidis, PhD, of the University of Arizona Mel and Enid Zuckerman College of Public Health in Tucson, and colleagues wrote, “It has been …
Read More »No Mortality Reduction in Type 2 Diabetes with Tight Glycemic Control
No effect of tight glycemic control on mortality or major cardiovascular events in long-term follow-up of the ADVANCE trial…. The Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE study) assessed the effects of routine blood-pressure lowering and strict glucose control in a broad cross …
Read More »Effect of Low HDL Cholesterol on Cancer Risk in Type 2 Diabetes Patients
Low HDL increases the risk of heart disease but does it also increase the risk of cancer?…
Read More »EASD: Fatty Dairy May Lower Type 2 Diabetes Risk
Eating a lot of higher fat dairy products seemed to lower the risk of type 2 diabetes development by up to 23%….
Read More »Weight Loss Lowers Health Care Costs for Type 2 Diabetic Patients
Overweight diabetic patients who lose weight by dieting and increasing their physical activity can reduce their health care costs by an average of around $600 per year….
Read More »Fibrates Can Reduce Cardiovascular Risk in Type 2’s
This study showed that fenofibrate was very effective in lowering total, LDL, non-HDL cholesterol significantly in female diabetic patients compared to male patients….
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.